Avenue Therapeutics Inc.

NASDAQ: ATXI · Real-Time Price · USD
0.50
-0.04 (-7.41%)
At close: Aug 11, 2025, 11:48 AM

Avenue Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.59M 1.78M 6.71M 3.76M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a 90K
Inventory
n/a n/a n/a n/a
Other Current Assets
78K 67K 137K n/a
Total Current Assets
2.67M 1.85M 6.84M 3.96M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a
Total Assets
2.67M 1.85M 6.84M 3.96M
Account Payables
155K 401K 150K 362K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
34K 784K 3.23M n/a
Total Current Liabilities
816K 1.2M 3.58M 509K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 949.00 n/a
Total Liabilities
816K 1.2M 3.58M 509K
Total Debt
n/a n/a n/a n/a
Common Stock
n/a 3K n/a 2K
Retained Earnings
-102.58M -90.93M -80.55M -77M
Comprehensive Income
n/a -0.00 n/a -0.00
Shareholders Equity
2.8M 1.58M 3.9M 3.45M
Total Investments
n/a n/a n/a n/a